The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Sep. 27, 2016

Filed:

Nov. 24, 2009
Applicants:

Leon Garcia-martinez, Woodinville, WA (US);

Anne Elisabeth Carvalho Jensen, Edmonds, WA (US);

Katie Olson, Kenmore, WA (US);

Ben Dutzar, Seattle, WA (US);

John Latham, Seattle, WA (US);

Brian Kovacevich, Snohomish, WA (US);

Jeffrey T. L. Smith, Redmond, WA (US);

Mark Litton, Seattle, WA (US);

Randall Schatzman, Redmond, WA (US);

Inventors:

Leon Garcia-Martinez, Woodinville, WA (US);

Anne Elisabeth Carvalho Jensen, Edmonds, WA (US);

Katie Olson, Kenmore, WA (US);

Ben Dutzar, Seattle, WA (US);

John Latham, Seattle, WA (US);

Brian Kovacevich, Snohomish, WA (US);

Jeffrey T. L. Smith, Redmond, WA (US);

Mark Litton, Seattle, WA (US);

Randall Schatzman, Redmond, WA (US);

Assignee:

ALDERBIO HOLDINGS LLC, Las Vegas, NV (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 39/395 (2006.01); C07K 16/24 (2006.01); A61K 51/10 (2006.01); A61K 49/00 (2006.01); A61K 39/00 (2006.01); C12P 21/08 (2006.01); C12N 15/63 (2006.01);
U.S. Cl.
CPC ...
A61K 51/1033 (2013.01); A61K 49/0058 (2013.01); C07K 16/248 (2013.01); A61K 2039/505 (2013.01); C07K 2316/96 (2013.01); C07K 2317/24 (2013.01); C07K 2317/34 (2013.01); C07K 2317/56 (2013.01); C07K 2317/565 (2013.01); C07K 2317/76 (2013.01); C07K 2317/92 (2013.01);
Abstract

The invention relates to the use of anti-IL-6 antibodies or antibody fragments containing a specific epitopic specificity to treat conditions involving elevated Il-6. In some embodiments the anti-IL-6 antibodies contain specific CDRs.


Find Patent Forward Citations

Loading…